These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35674885)

  • 1. Couples' Preferences for "2 in 1" Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe.
    Minnis AM; Etima J; Musara P; Browne EN; Mutero P; Kemigisha D; Mgodi NM; Nakabiito C; Shapley-Quinn MK; Stoner MCD; Hartmann M; Macagna N; Piper J; van der Straten A
    AIDS Behav; 2022 Dec; 26(12):3848-3861. PubMed ID: 35674885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Couples' decision making regarding the use of multipurpose prevention technology (MPT) for pregnancy and HIV prevention.
    Stoner MCD; Browne EN; Etima J; Musara P; Hartmann M; Shapley-Quinn MK; Kemigisha D; Mutero P; Mgodi NM; Nakabiito C; Bhushan NL; Piper J; van der Straten A; Minnis AM
    AIDS Behav; 2023 Jan; 27(1):198-207. PubMed ID: 35776249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making the Case for Joint Decision-Making in Future Multipurpose Prevention Technology (MPT) Choice: Qualitative Findings on MPT Attribute Preferences from the CUPID Study (MTN-045).
    Bhushan NL; Musara P; Hartmann M; Stoner MCD; Shah SR; Nabukeera J; Rukundo I; Mutero P; Lewis MA; Piper J; Shapley-Quinn MK; Etima J; Minnis AM
    J Int AIDS Soc; 2022 Oct; 25(10):e26024. PubMed ID: 36254362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perception of couples' on multipurpose prevention technology attribute choice: the case of MTN 045.
    Dandadzi A; Young AM; Musara P; Shapley-Quinn MK; Kemigisha D; Mutero P; Mgodi NM; Etima J; Minnis AA
    BMC Public Health; 2024 Jul; 24(1):1876. PubMed ID: 39004714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa.
    Minnis AM; Browne EN; Boeri M; Agot K; van der Straten A; Ahmed K; Weinrib R; Mansfield C
    J Acquir Immune Defic Syndr; 2019 Apr; 80(4):394-403. PubMed ID: 30633040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention.
    van der Straten A; Agot K; Ahmed K; Weinrib R; Browne EN; Manenzhe K; Owino F; Schwartz J; Minnis A;
    J Int AIDS Soc; 2018 Mar; 21(3):e25094. PubMed ID: 29600595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Young Women's Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa.
    Minnis AM; Roberts ST; Agot K; Weinrib R; Ahmed K; Manenzhe K; Owino F; van der Straten A;
    AIDS Behav; 2018 Aug; 22(8):2662-2673. PubMed ID: 29560570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. Women.
    Hynes JS; Sheth AN; Lathrop E; Sales JM; Haddad LB
    J Womens Health (Larchmt); 2019 May; 28(5):665-672. PubMed ID: 30615569
    [No Abstract]   [Full Text] [Related]  

  • 9. Giving voice to the end-user: input on multipurpose prevention technologies from the perspectives of young women in Kenya and South Africa.
    Minnis AM; Krogstad E; Shapley-Quinn MK; Agot K; Ahmed K; Danielle Wagner L; van der Straten A;
    Sex Reprod Health Matters; 2021 Dec; 29(1):1927477. PubMed ID: 34224341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferences, educational messaging, and demand creation channels for multipurpose-prevention technologies (MPTs) among women in South Africa.
    Mataboge P; Mthimkhulu N; Kutywayo A; Martin CE; Mazibuko M; Kwatsha K; Makalela N; Briedenhann E; Butler V; Bothma R; Mullick S
    BMC Public Health; 2023 Oct; 23(1):2090. PubMed ID: 37880628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention.
    Krovi SA; Johnson LM; Luecke E; Achilles SL; van der Straten A
    Adv Drug Deliv Rev; 2021 Sep; 176():113849. PubMed ID: 34186143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women Want Choices: Opinions from the Share.Learn.Shape Global Internet Survey About Multipurpose Prevention Technology (MPT) Products in Development.
    Friedland BA; Plagianos M; Savel C; Kallianes V; Martinez C; Begg L; Guthrie KM; Venkatasetty D; Pickett J; Haddad LB
    AIDS Behav; 2023 Jul; 27(7):2190-2204. PubMed ID: 36881183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing a multipurpose technology for acceptability and adherence.
    Tolley EE; Morrow KM; Owen DH
    Antiviral Res; 2013 Dec; 100 Suppl(0):S54-9. PubMed ID: 24188706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of end-user research to inform future multipurpose prevention technologies in sub-Saharan Africa: a scoping review.
    Bhushan NL; Ridgeway K; Luecke EH; Palanee-Phillips T; Montgomery ET; Minnis AM
    Front Reprod Health; 2023; 5():1156864. PubMed ID: 37325244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV.
    Young Holt B; Dellplain L; Creinin MD; Peine KJ; Romano J; Hemmerling A
    Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):326-334. PubMed ID: 30247084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-Users' Product Preference Across Three Multipurpose Prevention Technology Delivery Forms: Baseline Results from Young Women in Kenya and South Africa.
    Weinrib R; Minnis A; Agot K; Ahmed K; Owino F; Manenzhe K; Cheng H; van der Straten A
    AIDS Behav; 2018 Jan; 22(1):133-145. PubMed ID: 29052018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons from reproductive health to inform multipurpose prevention technologies: don't reinvent the wheel.
    Brady M; Manning J
    Antiviral Res; 2013 Dec; 100 Suppl():S25-31. PubMed ID: 24188700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interest in multipurpose prevention of HIV and pregnancy: perspectives of women, men, health professionals and community stakeholders in two vaginal gel studies in southern Africa.
    Woodsong C; Musara P; Chandipwisa A; Montgomery E; Alleman P; Chirenje M; Chipato T; Martinson F; Hoffman I
    BJOG; 2014 Oct; 121 Suppl 5():45-52. PubMed ID: 25335840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study.
    Montgomery ET; Beksinska M; Mgodi N; Schwartz J; Weinrib R; Browne EN; Mphili N; Musara P; Jaggernath M; Ju S; Smit J; Chirenje ZM; Doncel GF; van der Straten A
    J Int AIDS Soc; 2019 May; 22(5):e25283. PubMed ID: 31069957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United States.
    Hynes JS; Sales JM; Sheth AN; Lathrop E; Haddad LB
    Contraception; 2018 Mar; 97(3):277-284. PubMed ID: 29055782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.